← Evidence map

ArticlePulmonology

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors' reply.

A Cortegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 33158787